Literature DB >> 29217907

Synchronous Breast Cancer and Gallbladder Diseases-A Chromosomal Analysis: A Pilot Study at a Tertiary Care Centre.

Devendra Chaudhary1, Rahul Ahluwalia1,2, Arvind Rai1.   

Abstract

Out of a total of 50 study-eligible patients, 15 patients were found to have synchronous breast cancer and gallbladder diseases. Fourteen such patients had breast cancer and cholelithiasis while 1 patient had breast cancer with gallbladder cancer. Amongst these 15 patients, 7 patients tested positive for chromosomal aberrations on karyotyping. Aberrations in these patients were seen on chromosomes 13 and 17 with 2 patients having deletion 13q, 2 having deletion 17q, and 2 having deletions on 17p while one patient had multiple deletions on chromosomes 13q and 17p. The patient with multiple aberrations on 13q and 17p had a grade III infiltrating ductal carcinoma (NOS) of the breast with adenocarcinoma of the gallbladder. On the basis of our study and its analysis, we conclude that synchronous breast and gallbladder lesions are common amongst females and the occurrence of one should warn the clinician to search for the other. Also, chromosomal aberrations are common amongst patients with synchronous diseases and since these abnormalities are in the germ line cells, genetic counselling should be offered to the first- and second-degree female relatives.

Entities:  

Keywords:  BRCA1; BRCA2; Breast cancer; Cholangiocarcinoma; Cholelithiasis; Gallbladder; Gallbladder cancer; Lynch syndrome; p53

Year:  2016        PMID: 29217907      PMCID: PMC5711715          DOI: 10.1007/s12262-016-1524-8

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  14 in total

Review 1.  The evolving role of aromatase inhibitors in breast cancer.

Authors:  Kefah Mokbel
Journal:  Int J Clin Oncol       Date:  2002-10       Impact factor: 3.402

2.  A descriptive study of BRCA1 testing and reactions to disclosure of test results.

Authors:  H T Lynch; S J Lemon; C Durham; S T Tinley; C Connolly; J F Lynch; J Surdam; E Orinion; S Slominski-Caster; P Watson; C Lerman; P Tonin; G Lenoir; O Serova; S Narod
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

3.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

4.  Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.

Authors:  Erick Riquelme; Moying Tang; Sergio Baez; Alfonso Diaz; Martha Pruyas; Ignacio I Wistuba; Alejandro Corvalan
Journal:  Cancer Lett       Date:  2006-11-07       Impact factor: 8.679

5.  APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis.

Authors:  T Itoi; H Watanabe; Y Ajioka; Y Oohashi; K Takel; K Nishikura; Y Nakamura; A Horil; T Saito
Journal:  Pathol Int       Date:  1996-05       Impact factor: 2.534

Review 6.  Epidemiology and molecular pathology of gallbladder cancer.

Authors:  E C Lazcano-Ponce; J F Miquel; N Muñoz; R Herrero; C Ferrecio; I I Wistuba; P Alonso de Ruiz; G Aristi Urista; F Nervi
Journal:  CA Cancer J Clin       Date:  2001 Nov-Dec       Impact factor: 508.702

7.  Patients with gallstones develop gallbladder cancer at an earlier age.

Authors:  U Dutta; B Nagi; P K Garg; S K Sinha; K Singh; R K Tandon
Journal:  Eur J Cancer Prev       Date:  2005-08       Impact factor: 2.497

8.  Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol.

Authors:  Liqing Yu; Jia Li-Hawkins; Robert E Hammer; Knut E Berge; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.

Authors:  M Imai; T Hoshi; K Ogawa
Journal:  Cancer       Date:  1994-06-01       Impact factor: 6.860

10.  Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.

Authors:  A Wee; M Teh; G C Raju
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

View more
  1 in total

1.  Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma.

Authors:  Fei Zhou; Yanhua Zhang; Jihong Sun; Xiaoming Yang
Journal:  Cancer Cell Int       Date:  2019-07-22       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.